Hydrocortisone Sodium Succinate Injection — FDA Drug Shortage
The FDA lists a drug shortage record for Hydrocortisone Sodium Succinate Injection (injection) from Hospira, Inc., A Pfizer Company with status No longer listed by FDA. The shortage was first posted on Mar 24, 2023.
Shortage details
- Status
- No longer listed by FDA
- Company
- Hospira, Inc., A Pfizer Company
- Package NDC
- 0009-0011-03
- Dosage Form
- Injection
- Presentation
- Solu-Cortef, Injection, 100 mg/vial (NDC 0009-0011-03)
- Initial Posting
- Mar 24, 2023